Robot-assisted laparoscopic enucleation in the treatment of leiomyosarcoma of urinary bladder: A case report.
10.11817/j.issn.1672-7347.2023.220550
- Author:
Zhongyi ZENG
1
;
Xiao WU
2
;
Kai PENG
2
;
Da REN
2
;
Xuan ZHU
3
;
Lei ZHANG
4
Author Information
1. Department of Urology, Second Xiangya Hospital, Central South University, Changsha 410011, China. zengzhongyi@csu.edu.cn.
2. Department of Urology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
3. Department of Urology, Second Xiangya Hospital, Central South University, Changsha 410011, China. zhuxuan@csu.edu.cn.
4. Department of Urology, Second Xiangya Hospital, Central South University, Changsha 410011, China. zhanglei001@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
bladder cancer;
chemotherapy;
leiomyosarcoma;
robotic-assisted surgery
- MeSH:
Male;
Humans;
Adult;
Urinary Bladder/surgery*;
Leiomyosarcoma/secondary*;
Robotics;
Quality of Life;
Pelvis/pathology*;
Urinary Bladder Neoplasms/pathology*;
Laparoscopy/methods*
- From:
Journal of Central South University(Medical Sciences)
2023;48(5):782-788
- CountryChina
- Language:English
-
Abstract:
Leiomyosarcoma of urinary bladder (LMS-UB) is a highly malignant mesenchymal tumor, accounting for less than 0.5% of all bladder malignancies, with a predominant clinical presentation of hematuria. Here we report a case of low-grade LMS-UB. A 44-year-old male patient was admitted to the hospital with urodynia for 2 weeks. The patient's pelvis CT showed a mass on the right part of the bladder. For this reason, he was initially diagnosed with bladder cancer. We performed a robot-assisted laparoscopic enucleation of the bladder tumor and low-grade LMS-UB was diagnosed with the histopathological examination. He underwent 5 cycles of adjuvant chemotherapy after surgery. At 19months postoperative follow-up, the patient had no symptoms, recurrence, or distant metastasis. There is no report on the treatment of LMS-UB with minimally invasive enucleation worldwide. This case provides a new comprehensive treatment method of enucleation combined with adjuvant chemotherapy for early low-grade LMS-UB to reduce complications and improve patients' quality of life after surgery.
